Published in Evid Based Complement Alternat Med on March 03, 2015
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 14.07
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Controllability of complex networks. Nature (2011) 9.09
Mapping complex disease traits with global gene expression. Nat Rev Genet (2009) 7.44
Conserved pathways within bacteria and yeast as revealed by global protein network alignment. Proc Natl Acad Sci U S A (2003) 4.68
Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy. Chin J Integr Med (2012) 1.17
Management of stable coronary artery disease. Lancet (2010) 1.00
[Analysis of relationships among syndrome, therapeutic treatment, and Chinese herbal medicine in patients with coronary artery disease based on complex networks]. Zhong Xi Yi Jie He Xue Bao (2010) 0.97
Syndrome classification based on manifold ranking for viral hepatitis. Chin J Integr Med (2013) 0.93
Selecting an appropriate interestingness measure to evaluate the correlation between Chinese medicine syndrome elements and symptoms. Chin J Integr Med (2011) 0.88
Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches. Chin J Integr Med (2013) 0.88
[The criterion of syndrome differentiation and quantification for stable coronary heart disease caused by etiological toxin of Chinese medicine]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2011) 0.83
[Blood-stasis and toxin causing catastrophe hypothesis and acute cardiovascular events: proposal of the hypothesis and its clinical significance]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2008) 0.82
Therapeutic evaluation on complex interventions of integrative medicine and the potential role of data mining. Chin J Integr Med (2010) 0.80
Network based integrated analysis of phenotype-genotype data for prioritization of candidate symptom genes. Biomed Res Int (2014) 0.79
Use of evidence-based pharmacotherapy for secondary prevention of coronary heart disease: a Chinese medicine hospital versus a general hospital. Chin J Integr Med (2014) 0.78
Multifactor dimensionality reduction analysis of the correlation of Chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease. Chin J Integr Med (2014) 0.78
Network based integrated analysis of phenotype-genotype data for prioritization of candidate symptom genes. Biomed Res Int (2014) 0.79
Applications of data mining methods in the integrative medical studies of coronary heart disease: progress and prospect. Evid Based Complement Alternat Med (2014) 0.77
Cardiovascular Actions and Therapeutic Potential of Tetramethylpyrazine (Active Component Isolated from Rhizoma Chuanxiong): Roles and Mechanisms. Biomed Res Int (2016) 0.76
Network-Based Approach to Identify Potential Targets and Drugs that Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke. Sci Rep (2017) 0.75
Complementary/Alternative Medicine in Cardiovascular Diseases 2014. Evid Based Complement Alternat Med (2015) 0.75